Literature DB >> 31443769

The sour side of vitamin C might mediate neuroprotective, anticonvulsive and antidepressant-like effects.

Udo Bonnet1.   

Abstract

In animal experiments, neuroprotective, anticonvulsive and antidepressant-like properties have been increasingly attributed to administrations of ascorbic acid (AA, vitamin C) in at least medium (low millimolar) doses, which however await validation in well controlled clinical studies. In mammalian cortical and subcortical neurons, small to modest acidification (<0.4-0.5 pH-units) is belonging to the key strategies for controlling local excitability and is associated with neuroprotection, e.g. by limiting excitotoxicity. Such acidifications are furthermore involved in the mechanisms of some anticonvulsants and antidepressants. As AA-transport and regulation of intracellular pH (pHi) are closely interwoven on the level of special transmembrane solute carriers, I suppose that the aforementioned beneficial AA-effects might be based upon a discrete "hormetic" acidification of cortical and or subcortical neurons via an AA-mediated weakening of their pHi-regulation. This assumption is supported by findings in non-neuronal cells suggesting both, intracellular acidification and inhibition of a core-element of the pHi-regulation apparatus by millimolar AA. In mammalian subcortical neurons, there is already first evidence of a modest acidification after adding low millimolar AA.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ascorbic acid; Epilepsy; Intracellular acidification; Neuroprotection; Neuropsychiatric disorders; Oxidative stress; pH-regulation

Mesh:

Substances:

Year:  2019        PMID: 31443769     DOI: 10.1016/j.mehy.2019.109320

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

Review 1.  Antioxidant Therapies for Neuroprotection-A Review.

Authors:  Raluca Ioana Teleanu; Cristina Chircov; Alexandru Mihai Grumezescu; Adrian Volceanov; Daniel Mihai Teleanu
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

Review 2.  COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review.

Authors:  Udo Bonnet; Georg Juckel
Journal:  J Clin Psychopharmacol       Date:  2022-04-14       Impact factor: 3.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.